Date:11/19/2009

the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release, the Company's strategic operational plans, as well as its outlook for 3Q FY2009, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

    For more information, please contact:

     Sam Tsang and Winnie Yam
     Tel:   +852-2511-9808
     Email: IR@chinameditech.com



    China Medical Technologies, Inc.
    Unaudited Condensed Consolidated Balance Sheets

                                                  As of
                                   March 31, 2009         September 30, 2009
                                  RMB          RMB          RMB       US$
                           As previously       As
                               reported    adjusted(1)
                                             (in thousands)
    Assets
    Current assets
    Cash and cash
     equivalents              1,456,410    1,456,410    1,236,696    181,169
    Trade accounts
     receivable, net            343,037      343,037      317,874     46,566
    Inventories                  16,932       16,93
'/>"/>
SOURCE  China Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Related medicine news :

1. China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009
2. Jiangbo Pharmaceuticals to Present at Brean Murray, Carret 2009 China Growth Conference
3. Novartis to Acquire Majority Stake in Hard to Treat Diseases (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million
4. Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin
5. HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China
6. China Nepstar Enters Into Strategic Cooperation Agreement with ATMU to Install More Than 1,000 ATMs in Nepstar Stores
7. China Medical Technologies to Announce Unaudited Financial Results for the Second Fiscal Quarter Ended September 30, 2009 on November 19, 2009
8. China Pharma Holdings, Inc. to Report Third Quarter 2009 Financial Results on November 12, 2009
9. Perot Systems Announces Strategic Alliance With China Telecom
10. China Medicine Corporations Levocarnitine Dried Powder Injection Was Registered with the Ministry of Health of Pakistan
11. Niusule Launches Niusule Gummy Bears in China